Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this?
Related Articles
News
A single PSA test in asymptomatic men has no mortality benefit
Senza categoria
N E W S R O U N D
Spotlight on
Leave a Reply